Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Resmed (RMD)
NYSE:RMD
Holding RMD?
Track your performance easily
RMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$132.24 - $255.18
Previous Close$250.88
Volume1.89M
Average Volume (3M)1.10M
Market Cap
$36.86B
Enterprise Value$37.50B
Total Cash (Recent Filing)$238.36M
Total Debt (Recent Filing)$873.93M
Price to Earnings (P/E)36.4
Beta1.14
Next Earnings
Oct 24, 2024EPS Estimate
$2.05Last Dividend Ex-Date
Aug 15, 2024Dividend Yield0.78%
Share Statistics
EPS (TTM)6.92
Shares Outstanding146,932,119
10 Day Avg. Volume939,773
30 Day Avg. Volume1,099,987
Standard Deviation0.09
R-Squared0.15
Alpha0.00587
Financial Highlights & Ratios
Price to Book (P/B)7.58
Price to Sales (P/S)7.90
Price to Cash Flow (P/CF)20.80
P/FCF Ratio22.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.12
Enterprise Value/Gross Profit14.12
Enterprise Value/Ebitda26.79
Forecast
1Y Price Target
$214.20Price Target Upside-10.01% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Resmed News
PremiumMarket News
VOO ETF Update, 9/19/2024 
PremiumThe Fly
ResMed falls -4.8%
PremiumThe Fly
ResMed falls -6.8%
PremiumMarket News
SPY ETF Update, 9/17/2024 
PremiumMarket News
VOO ETF Update, 9/16/2024 Bulls Say, Bears Say
Bulls Say
Market DynamicsCompetitor recall tailwinds supporting revenue growth.
Operational EfficiencyRMD's gross margin was up 330 bps Y/Y and its operating margin was up 530 bps Y/Y due to pricing, product mix, lower freight costs, and its recent restructuring.
Revenue GrowthRMD's F4Q24 revenue beat and EPS met consensus and its organic revenue growth improved to 10% from 7% in F3Q24 as it faced an easier comp.
Bears Say
Drug ImpactThere is a risk that the impact from GLP-1 drugs could be worse than expected.
EarningsRMD's margins have benefited from a variety of factors, but margin improvement is expected to slow in FY25 and beyond.
Market ShareRMD's flow generator share gains may have peaked and that mask share gains may be more difficult.
---
Ownership Overview
2.67% Insiders
22.37% Mutual Funds
31.79% Other Institutional Investors
43.17% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RMD FAQ
What was Resmed’s price range in the past 12 months?
Resmed lowest stock price was $132.24 and its highest was $255.18 in the past 12 months.
What is Resmed’s market cap?
Currently, no data Available
When is Resmed’s upcoming earnings report date?
Resmed’s upcoming earnings report date is Oct 24, 2024 which is in 35 days.
How were Resmed’s earnings last quarter?
Resmed released its earnings results on Aug 01, 2024. The company reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.083 by -$0.003.
Is Resmed overvalued?
According to Wall Street analysts Resmed’s price is currently Overvalued.
Does Resmed pay dividends?
Resmed pays a Quarterly dividend of $0.53 which represents an annual dividend yield of 0.78%. See more information on Resmed dividends here
What is Resmed’s EPS estimate?
Resmed’s EPS estimate is $2.05.
How many shares outstanding does Resmed have?
Resmed has 146,932,110 shares outstanding.
What happened to Resmed’s price movement after its last earnings report?
Resmed reported an EPS of $2.08 in its last earnings report, missing expectations of $2.083. Following the earnings report the stock price went up 4.233%.
Which hedge fund is a major shareholder of Resmed?
Among the largest hedge funds holding Resmed’s share is Greenvale Capital LLP. It holds Resmed’s shares valued at 139M.
---
Resmed Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$214.20 (-10.01% Downside)
$214.20 (-10.01% Downside)
Blogger Sentiment
Bullish
RMD Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 181.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $10.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 2.1%
Last 30 Days ▼ 2.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
74.34%
12-Months-Change
Fundamentals
Return on Equity
22.70%
Trailing 12-Months
Asset Growth
1.79%
Trailing 12-Months
Company Description
Resmed
Founded in 1989, California-based ResMed, Inc. is a medical equipment company. The company is engaged in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through two segments: Sleep and Respiratory Care, and SaaS (Software as a Service).
---
RMD Company Deck
---
RMD Earnings Call
Q4 2024
0:00 / 0:00
---
RMD Revenue Breakdown
52.16% Devices
35.37% Masks and other
12.47% Software as a Service
---
RMD Stock 12 Month Forecast
Average Price Target
$214.20
▼(-10.01% Downside)
Technical Analysis
Best Analysts Covering RMD
1 Year
1 Year Success Rate
12/16 ratings generated profit
1 Year Average Return
+20.24%
reiterated a buy rating 2 months ago
Copying Lyanne Harrison's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +20.24% per trade.
---